taVNS for relieving symptoms of moderate-to-severe chronic prostatitis/CPPS
Official title: Effect of Transcutaneous Auricular Vagus Nerve Stimulation on Moderate to Severe Chronic Prostatitis/Chronic Pelvic Pain Syndrome (TASC-P Trial): a Randomized, Sham Controlled Trial.
Run by Guang'anmen Hospital of China Academy of Chinese Medical Sciences · NCT06287970 · Data updated 2026-11-12
This trial will try transcutaneous auricular vagus nerve stimulation (taVNS) to see if it reduces pain and urinary and mood symptoms in adults aged 18–50 with moderate to severe chronic prostatitis/CPPS.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 50 Years |
| Sex | Men only |
| Enrollment | 68 (estimated) |
| Sponsor | Guang'anmen Hospital of China Academy of Chinese Medical Sciences Academic / other |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Status | Recruiting |
| Started | March 15, 2024 |
| Main results expected | December 31, 2026 |
| Study ends | February 18, 2027 |
| Registry record updated | November 28, 2025 |
| Trial ID | NCT06287970 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–50 diagnosed with CP/CPPS (symptoms >3 months in the last 6 months) with NIH-CPSI score ≥15, without infection or other clear pathological causes, are the intended participants.
✕Probably not a fit
People outside the 18–50 age range, those with infectious or other identifiable causes of pelvic pain, or those with only mild CP/CPPS symptoms (NIH-CPSI <15) are unlikely to benefit from this trial.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, randomized, sham-controlled trial enrolling 68 patients with moderate-to-severe CP/CPPS who meet EAU/CAU diagnostic criteria. Participants will be randomized 1:1 to receive either active taVNS or a sham taVNS intervention for 4 weeks, with an 8-week follow-up after treatment. Outcomes include NIH-CPSI, IPSS, EQ-5D, and measures of anxiety and depression (SAS, SDS), and adverse events will be recorded throughout. The trial is conducted at Guang'anmen Hospital, China Academy of Chinese Medical Sciences in Beijing.
Why it matters
Potential benefit: If successful, taVNS could offer a noninvasive treatment option to reduce pelvic pain and improve urinary symptoms and quality of life for people with CP/CPPS.
How similar studies have gone: Noninvasive vagus nerve stimulation has shown promise for some chronic pain and mood disorders, but applying taVNS specifically to CP/CPPS is relatively novel with limited prior data.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Consistent with the diagnostic criteria of CP/CPPS of EAU or CAU, the clinical manifestations were recurrent and persistent prostate pain accompanied by abnormal urination and psychiatric symptoms, without infection or other obvious pathological conditions. The pain symptoms were mainly manifested as pain in the surrounding tissues centered on the prostate, and pain, swelling or discomfort in the scrotum, testis, lower abdomen, perineum, lumbosacral area, and medial thigh. Abnormal urination was characterized by frequent urination, urgent urination, urination pain, urethral burning, residual urination or white discharge from the urethra at the end of urination or defecation in the morning. The neuropsychiatric symptoms included dizziness and tinnitus, insomnia and dreams, anxiety and depression, and even impotence, premature ejaculation, and spermatorrhea. Symptoms lasting more than 3 months in the last six months * 18 ≤ Age ≤ 50 years old * NIH-CPSI ≥15 (patients with moderate to severe CP/CPPS) * Signed informed consent and voluntarily participated in the trial Exclusion Criteria: * Patients with other diseases that cause urinary symptoms were excluded: Such as benign prostatic hyperplasia, testicular and epididymal and spermatic cord diseases, overactive bladder, neurogenic bladder, interstitial cystitis, glandular cystitis, sexually transmitted diseases, bladder tumors such as carcinoma in situ, prostate cancer, urinary male reproductive system tuberculosis, anorectal diseases, lumbar diseases, central and peripheral neuropathy, etc * Patients with severe diseases of the heart, liver, kidney, hematopoietic system and poor nutritional status * Patients with severe mental and emotional disorders, who were unable to cooperate with the study * Patients who have been treated with CP/CPPS regimen in the past 4 weeks
Where it's running
-
Guang'anmen Hospita, China Academy of Chinese Medical Sciences
Beijing, Beijing Municipality, China Recruiting
Study contacts
- Study coordinator: Jiani Wu
- Email: jiani_wu@aliyun.com
- Phone: +8613426116653
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Assessing pain types in treating bladder pain syndrome
This study is trying to see how different types of bladder pain affect how well people with bladder pain syndrome respond to pelvic floor physical therapy and cognitive-behavioral therapy.
-
Pelvic floor training for men with chronic pelvic pain
This study is testing if pelvic floor exercises and biofeedback can help men with chronic pelvic pain feel better over six months compared to those who continue their usual treatment.
-
Comparing low-intensity shockwave and radial wave treatments for erectile dysfunction and pelvic pain
This study is testing whether focused shockwave therapy or radial wave therapy can help men with erectile dysfunction and people with chronic pelvic pain feel better.
-
A program to ease pelvic pain through cognitive behavioral therapy
This study is testing a short program of cognitive behavioral therapy to see if it can help people with chronic pelvic pain feel better compared to regular patient education.
-
Genetic analysis of chronic pelvic pain conditions
This study is trying to find out if certain genes are linked to chronic pelvic pain by collecting samples from people with the condition and their families.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.